J. Kleinnijenhuis, M. Oosting, L. A. Joosten, and M. G. Netea, Van Crevel R. Innate immune recognition of Mycobacterium tuberculosis, Clin Dev Immunol, 2011.

L. Tailleux, O. Schwartz, J. L. Herrmann, E. Pivert, M. Jackson et al., DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells, J Exp Med, vol.197, pp.121-128, 2003.
URL : https://hal.archives-ouvertes.fr/pasteur-01372712

A. Baena and S. A. Porcelli, Evasion and subversion of antigen presentation by Mycobacterium tuberculosis, Tissue Antigens, vol.74, pp.189-204, 2009.

N. F. Walker, C. Stek, S. Wasserman, R. J. Wilkinson, and G. Meintjes, The tuberculosisassociated immune reconstitution inflammatory syndrome: recent advances in clinical and pathogenesis research, Curr Opin HIV AIDS, vol.13, pp.512-533, 2018.

D. Laureillard, O. Marcy, Y. Madec, S. Chea, S. Chan et al., Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial, AIDS, vol.27, pp.2577-86, 2013.

K. Naidoo, N. Yende-zuma, N. Padayatchi, K. Naidoo, N. Jithoo et al., The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial, Ann Intern Med, vol.157, pp.313-337, 2012.

A. F. Luetkemeyer, M. A. Kendall, M. Nyirenda, X. Wu, P. Ive et al., Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs, J Acquir Immune Defic Syndr, vol.65, pp.423-431, 2014.

R. P. Lai, G. Meintjes, K. A. Wilkinson, C. M. Graham, S. Marais et al., HIV-tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling, Nat Commun, vol.6, p.8451, 2015.

F. Conradie, A. S. Foulkes, P. Ive, X. Yin, K. Roussos et al., Natural killer cell activation distinguishes Mycobacterium tuberculosismediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection, J Acquir Immune Defic Syndr, vol.58, pp.309-327, 2011.

P. Pean, E. Nerrienet, Y. Madec, L. Borand, D. Laureillard et al., Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis, Blood, vol.119, pp.3315-3335, 2012.

A. Bourgarit, G. Carcelain, A. Samri, C. Parizot, M. Lafaurie et al., Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells, J Immunol, vol.183, pp.3915-3938, 2009.

S. T. Ribeiro, J. C. Ribot, and B. Silva-santos, Five layers of receptor signaling in gammadelta T-cell differentiation and activation, Front Immunol, vol.6, p.15, 2015.

M. Lawand, J. Dechanet-merville, and M. C. Dieu-nosjean, Key Features of gamma-delta T-cell subsets in human diseases and their immunotherapeutic implications. Front Immunol, vol.8, p.761, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01564945

P. Vantourout and A. Hayday, Six-of-the-best: unique contributions of gammadelta T cells to immunology, Nat Rev Immunol, vol.13, pp.88-100, 2013.

A. C. Belkina, A. Starchenko, K. A. Drake, E. A. Proctor, R. Pihl et al., Multivariate computational analysis of gamma delta T cell inhibitory receptor signatures reveals the divergence of healthy and ART-suppressed HIV+ aging, Annu Rev Immunol, vol.9, pp.297-336, 2007.

A. C. Rothchild, P. Jayaraman, C. Nunes-alves, and S. M. Behar, iNKT cell production of GM-CSF controls Mycobacterium tuberculosis, PLoS Pathog, vol.10, p.1003805, 2014.

S. P. Berzins, M. J. Smyth, and A. G. Baxter, Presumed guilty: natural killer T cell defects and human disease, Nat Rev Immunol, vol.11, pp.131-173, 2011.

C. S. Fernandez, A. D. Kelleher, R. Finlayson, D. I. Godfrey, and S. J. Kent, NKT cell depletion in humans during early HIV infection, Immunol Cell Biol, vol.92, pp.578-90, 2014.

J. S. Sutherland, D. J. Jeffries, S. Donkor, W. B. Hill, P. C. Adetifa et al., High granulocyte/lymphocyte ratio and paucity of NKT cells defines TB disease in a TB-endemic setting, Tuberculosis, vol.89, pp.398-404, 2009.

C. J. Montoya, J. C. Catano, Z. Ramirez, M. T. Rugeles, S. B. Wilson et al., Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype, Clin Immunol, vol.127, pp.1-6, 2008.

K. A. Wilkinson, N. F. Walker, G. Meintjes, A. Deffur, M. P. Nicol et al., Cytotoxic mediators in paradoxical HIV-tuberculosis immune reconstitution inflammatory syndrome, J Immunol, vol.194, pp.1748-54, 2015.

F. X. Blanc, T. Sok, D. Laureillard, L. Borand, C. Rekacewicz et al., Earlier versus later start of antiretroviral therapy in HIVinfected adults with tuberculosis, N Engl J Med, vol.365, pp.1471-81, 2011.

B. Rincon-orozco, V. Kunzmann, P. Wrobel, D. Kabelitz, A. Steinle et al., Activation of V gamma 9V delta 2 T cells by NKG2D, J Immunol, vol.175, pp.2144-51, 2005.

G. Matusali, H. K. Tchidjou, G. Pontrelli, S. Bernardi, D. 'ettorre et al., Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells, FASEB J, vol.27, pp.2440-50, 2013.

L. Szereday, Z. Baliko, and J. Szekeres-bartho, The role of Vdelta2+T-cells in patients with active Mycobacterium tuberculosis infection and tuberculin anergy, Int J Tuberc Lung Dis, vol.12, pp.262-270, 2008.

M. Garand, M. Goodier, O. Owolabi, S. Donkor, B. Kampmann et al., Functional and phenotypic changes of natural killer cells in whole blood during Mycobacterium tuberculosis infection and disease, Front Immunol, vol.9, p.257, 2018.

H. Fausther-bovendo, N. Wauquier, J. Cherfils-vicini, I. Cremer, P. Debre et al., NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells, AIDS, vol.22, pp.217-243, 2008.

H. Dolstra, H. Fredrix, A. Van-der-meer, T. De-witte, C. Figdor et al., TCR gamma delta cytotoxic T lymphocytes expressing the killer cell-inhibitory receptor p58.2 (CD158b) selectively lyse acute myeloid leukemia cells, Bone Marrow Transplant, vol.27, pp.1087-93, 2001.

V. Naranbhai, M. Altfeld, S. S. Karim, T. Ndung'u, Q. A. Karim et al., Changes in Natural Killer cell activation and function during primary HIV-1 Infection, PLoS ONE, vol.8, p.53251, 2013.

M. Carrington, M. P. Martin, and J. Van-bergen, KIR-HLA intercourse in HIV disease, Trends Microbiol, vol.16, pp.620-627, 2008.

S. Gaudieri, D. Desantis, E. Mckinnon, C. Moore, D. Nolan et al., Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression, Genes Immun, vol.6, pp.683-90, 2005.

M. A. Exley, R. Hou, A. Shaulov, E. Tonti, P. Dellabona et al., Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop, Eur J Immunol, vol.38, pp.1756-66, 2008.

Y. Jiang, X. Cui, C. Cui, J. Zhang, F. Zhou et al., The function of CD3+CD56+ NKT-like cells in HIV-infected individuals, Biomed Res Int, p.863625, 2014.

S. D. Lawn, H. Wainwright, and C. Orrell, Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages, AIDS, vol.23, pp.143-148, 2009.

H. Y. Tan, Y. K. Yong, E. M. Shankar, G. Paukovics, R. Ellegard et al., Aberrant inflammasome activation characterizes tuberculosisassociated immune reconstitution inflammatory syndrome, J Immunol, vol.196, pp.4052-63, 2016.

S. Ravimohan, N. Tamuhla, K. Nfanyana, A. P. Steenhoff, R. Letlhogile et al., Robust reconstitution of tuberculosis-specific polyfunctional CD4+

, T-cell responses and rising systemic interleukin 6 in paradoxical tuberculosisassociated immune reconstitution inflammatory syndrome, Clin Infect Dis, vol.62, pp.795-803, 2016.

V. Haridas, P. Pean, L. D. Jasenosky, Y. Madec, D. Laureillard et al., TB-IRIS, T-cell activation, and remodeling of the T-cell compartment in highly immunosuppressed HIV-infected patients with TB, AIDS, vol.29, pp.263-73, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02137135

Z. A. Sullivan, E. B. Wong, T. Ndung'u, K. Vo, and W. R. Bishai, Latent and active tuberculosis infection increase immune activation in individuals co-infected with HIV, EBioMed, vol.2, pp.334-374, 2015.

D. A. Kosub, G. Lehrman, J. M. Milush, D. Zhou, E. Chacko et al., Gamma/Delta T-cell functional responses differ after pathogenic human immunodeficiency virus and nonpathogenic simian immunodeficiency virus infections, J Virol, vol.82, pp.1155-65, 2008.

A. Poggi, R. Carosio, D. Fenoglio, S. Brenci, G. Murdaca et al., Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat, Blood, vol.103, pp.2205-2218, 2004.

A. C. Carvalho, A. Matteelli, P. Airo, S. Tedoldi, C. Casalini et al., gammadelta T lymphocytes in the peripheral blood of patients with tuberculosis with and without HIV co-infection, Front Immunol, vol.57, p.687, 2002.

A. Maniar, X. Zhang, W. Lin, B. R. Gastman, C. D. Pauza et al., Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement, Blood, vol.116, pp.1726-1759, 2010.

N. Shrestha, J. A. Ida, A. S. Lubinski, M. Pallin, G. Kaplan et al., Regulation of acquired immunity by gamma delta T-cell/dendritic-cell interactions, Ann N Y Acad Sci, vol.1062, pp.79-94, 2005.

S. S. Hassan, J. E. Cho, M. Akram, K. L. Fielding, H. M. Dockrell et al., Modulation of NKG2D expression in human CD8(+) T cells corresponding with tuberculosis drug cure, PLoS ONE, vol.8, 2013.

V. R. Parasa, R. Sikhamani, and A. Raja, Effect of recombinant cytokines on the expression of natural killer cell receptors from patients with TB or/and HIV infection, PLoS ONE, vol.7, p.37448, 2012.

R. Vankayalapati, A. Garg, A. Porgador, D. E. Griffith, P. Klucar et al., Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium, J Immunol, vol.175, pp.4611-4618, 2005.

J. Haik, G. Nardini, N. Goldman, G. Galore-haskel, M. Harats et al., Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns, Oncotarget, vol.7, pp.2220-2228, 2016.

H. R. Salih, S. Holdenrieder, and A. Steinle, Soluble NKG2D ligands: prevalence, release, and functional impact, Front Biosci, vol.13, pp.3448-56, 2008.

S. Chaudhry, C. Cairo, V. Venturi, and C. D. Pauza, The gammadelta T-cell receptor repertoire is reconstituted in HIV patients after prolonged antiretroviral therapy, AIDS, vol.27, pp.1557-62, 2013.

J. Bordon, P. S. Evans, N. Propp, C. E. Davis, R. R. Redfield et al., Association between longer duration of HIV-suppressive therapy and partial recovery of the V gamma 2 T cell receptor repertoire, J Infect Dis, vol.189, pp.1482-1488, 2004.

M. Carrington and G. Alter, Innate immune control of HIV. Cold Spring Harb Perspect Med, vol.2, p.7070, 2012.

D. Paquin-proulx, P. R. Costa, T. Silveira, C. G. Marmorato, M. P. Cerqueira et al., Latent Mycobacterium tuberculosis infection is associated with a higher frequency of mucosal-associated invariant T and invariant natural killer T cells, Front Immunol, vol.9, p.1394, 2018.

S. M. Bachle, D. F. Malone, M. Buggert, A. C. Karlsson, P. E. Isberg et al., Elevated levels of invariant natural killer T-cell and natural killer cell activation correlate with disease progression in HIV-1 and HIV-2 infections, AIDS, vol.30, pp.1713-1735, 2016.

M. Moll, C. Kuylenstierna, V. D. Gonzalez, S. K. Andersson, L. Bosnjak et al., Severe functional impairment and elevated PD-1 expression in CD1d-restricted NKT cells retained during chronic HIV-1 infection, Eur J Immunol, vol.39, pp.902-913, 2009.

N. F. Walker, C. Opondo, G. Meintjes, N. Jhilmeet, J. S. Friedland et al., Invariant natural killer T cell dynamics in HIV-associated tuberculosis, Clin Infect Dis, 2019.

H. J. Van-der-vliet, M. G. Van-vonderen, J. W. Molling, H. J. Bontkes, M. Reijm et al., Cutting edge: rapid recovery of NKT cells upon institution of highly active antiretroviral therapy for HIV-1 infection, J Immunol, vol.177, pp.5775-5783, 2006.

C. Germain, A. Meier, T. Jensen, P. Knapnougel, G. Poupon et al., Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-gamma contributes to modulate immune responses, J Biol Chem, vol.286, pp.37964-75, 2011.

L. Maggi, V. Santarlasci, M. Capone, A. Peired, F. Frosali et al., CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC, Eur J Immunol, vol.40, pp.2174-81, 2010.

J. E. Snyder-cappione, C. P. Loo, K. I. Carvalho, C. Kuylenstierna, S. G. Deeks et al., Lower cytokine secretion ex vivo by natural killer T cells in HIVinfected individuals is associated with higher CD161 expression, AIDS, vol.23, pp.1965-70, 2009.

H. J. Van-der-vliet, V. Blomberg, B. M. Hazenberg, M. D. Nishi, N. Otto et al., Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection, J Immunol, vol.168, pp.1490-1495, 2002.

J. K. Sandberg, C. A. Stoddart, F. Brilot, K. A. Jordan, and D. F. Nixon, Development of innate CD4+ alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7, Proc Natl Acad Sci, vol.101, pp.7058-63, 2004.